Pharma supply chains suffer on regulations

Regulatory pressures are at the top of the list of supply chain concerns voiced by pharmaceutical manufacturers in an annual UPS poll. Among respondents with more than $1 billion in sales, an increased regulatory burden was the top concern of 56 percent, while this factor topped the list for a third of smaller drugmakers. Report